 Home > Medical News > Latest Medical News > Fosun Pharma terminates Phase I clinical and follow-up development of SGLT-2 inhibitors

Fosun Pharma terminates Phase I clinical and follow-up development of SGLT-2 inhibitors

 Last Update: 2022-01-09
 Source: Internet
 Author: User

Tags

new treatment tourette's

order based book

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

On December 28, Fosun Pharma issued an announcement stating that its subsidiary, Jiangsu Wanbang, had decided to terminate the clinical trial and subsequent development of the SGLT-2 inhibitor vanagliflozin

Vangligliflozin is an SGLT-2 inhibitor introduced by IMC from Sirona Biochem in January 2014 and is intended to be used in the treatment of type II diabetes

As of now, the domestic market SGLT-2 inhibitors include AstraZeneca An Datang ®, Boehringer Ingelheim International Inc.

Since vanagliflozin is still in the phase I clinical trial stage, and many SGLT-2 inhibitors have been launched at home and abroad, the market competition has been relatively fierce, after careful consideration, based on factors such as investment in the subsequent development of the new drug and market value In order to rationally allocate R&D resources and focus on advantageous projects in the R&D pipeline, Jiangsu Wanbang decided to terminate the clinical trial and subsequent development of the new drug

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.